Thursday 9 May 2019

First randomized controlled trial of FMT for obesity shows potential progress

Using capsules filled with fecal matter from a lean donor, researchers successfully changed some of the composition of the gut microbiota of patients with obesity, a possible step toward a new treatment for weight loss. In the first randomized controlled trial of fecal microbiota transplantation (FMT) in metabolically healthy people with obesity, researchers presenting at Digestive Disease Week (DDW) 2019 said they were encouraged they could induce changes among the trillions of microorganisms and their genetic material within the intestinal tract.

* This article was originally published here